bioLIVE JapanbioLIVE Japan

bioLIVE Japan drives the advancement of Japan's biomedical technology sector. Focusing on life sciences, biotechnology, and innovative pharmaceuticals, it spearheads innovation and industrial development in biomedicine. Cutting-edge global technologies, including contract research and manufacturing services (CRO/CDMO) and advanced equipment, will converge at the event.

bioLIVE Japan covered a total exhibition area of 30,000 square meters in its previous edition, hosting 712 exhibitors from China, South Korea, India, Thailand, Russia, the United States, Germany, and other nations, with 24,800 attendees. Additionally, regenerative medicine and mid-molecule therapeutics, such as peptide and nucleic acid drugs, have gained significant traction in recent years. These emerging themes will be highlighted, with the latest technologies, products, and contract services presented through specialized seminars.

Driven by continuous breakthroughs in frontier biotechnologies and the commercialization of novel target therapeutics and cell therapies, the biomedical industry has entered a new phase of rapid growth. bioLIVE Japan serves as the premier trade platform for Chinese biomedical enterprises to expand into the Japanese market.